NCT02758158

Tri-modal Imaging Instrument for Thyroid Cancer

Clinical Evaluation of a Prototype Tri-modal Imaging Instrument for Thyroid Cancer

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 9 (actual)
• Sponsor: University Health Network, Toronto · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Thyroid cancer affects 6,000 Canadians each year. Nodules on the thyroid are detected using ultrasound imaging and surgery is the most common treatment. However, most nodules are benign, and therefore a biopsy is needed to decide whether surgery is necessary. Ultrasound imaging is very sensitive for localizing nodules, but does not differentiate between cancerous and benign ones. To address this limitation of US imaging, investigators have designed and constructed, in collaboration with Sogang University, Seoul, S. Korea, a novel imaging system that performs complimentary imaging modalities (ultrasound (US), photoacoustic (PA)) that could potentially help diagnose nodules without the need for biopsy and unnecessary surgery.

Conditions

• Thyroid Neoplasms
• Thyroid Cancer
• Thyroid Nodule

Interventions

Type	Name	Description
DEVICE	Tri-modal imaging	This trimodal imaging system was developed in collaboration with Sogang University and is composed of three subsystems: ultrasound, photoacoustic and fluorescence. For this study, the fluorescence subsystem will not be used. The photoacoustic and ultrasound subsystems and data acquisition are controlled by a single workstation. The complete system is Canadian Standards Association (CSA) certified.

Timeline

• Start date: 2016-01-01
• Primary completion: 2017-02-01
• Completion: 2017-02-01
• First posted: 2016-05-02
• Last updated: 2017-10-19

Locations

1 site across 1 country: Canada